Twist Bioscience Corporation (TWST) /
The debt of Twist Bioscience Corporation over the past 9 years
Chart Twist Bioscience Corporation: liquid cash, total debt, net cash, fiscal 2017–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Twist Bioscience Corporation had liquid cash of $232.43M and total debt of $15M: net cash of $217.43M. It had more liquid cash than debt at all 8 year-ends shown. Total debt was highest at the end of fiscal 2025 ($15M) and lowest at the end of fiscal 2022 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Sep 30, 2025 | $232.43M* | $15M | $217.43M |
| 2024ended Sep 30, 2024 | $276.4M* | $0 | $276.4M |
| 2023ended Sep 30, 2023 | $336.41M* | $0 | $336.41M |
| 2022ended Sep 30, 2022 | $504.97M* | $0 | $504.97M |
| 2021ended Sep 30, 2021 | $477.86M* | $1.55M | $476.31M |
| 2020ended Sep 30, 2020 | $290M* | $4.74M | $285.27M |
| 2019ended Sep 30, 2019 | $138.11M* | $7.73M | $130.37M |
| 2018ended Sep 30, 2018 | $80.76M | $9.72M | $71.04M |
| 2017ended Sep 30, 2017 | — | — | — |
Fiscal years as Twist Bioscience Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Twist Bioscience Corporation
- The revenue of Twist Bioscience Corporation
- The profitability of Twist Bioscience Corporation
- The cash flow of Twist Bioscience Corporation
- All of Twist Bioscience Corporation's financials, charted
Companies of a similar size
- HQYHEALTHEQUITY, INC.
- PCVXVaxcyte, Inc.
- FLSFLOWSERVE CORP
- ZETAZeta Global Holdings Corp.
- BRKRBRUKER CORPORATION
Not investment advice. This page shows what Twist Bioscience Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.